Reference |
---|
Falchi F, Maccagni E, Puccio S, Peano C, De Castro C, Palmigiano A, et al. Mutation and Suppressor Analysis of the Essential Lipopolysaccharide Transport Protein LptA Reveals Strategies To Overcome Severe Outer Membrane Permeability Defects in Escherichia coli. J Bacteriol. 2018;200: pubmed publisher
|
Tsuneyoshi N, Kohara J, Bahrun U, Saitoh S, Akashi S, Gauchat J, et al. Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction. Cell Immunol. 2006;244:57-64 pubmed
|
Sperandeo P, Cescutti R, Villa R, Di Benedetto C, Candia D, Dehò G, et al. Characterization of lptA and lptB, two essential genes implicated in lipopolysaccharide transport to the outer membrane of Escherichia coli. J Bacteriol. 2007;189:244-53 pubmed
|
Kohara J, Tsuneyoshi N, Gauchat J, Kimoto M, Fukudome K. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli. Protein Expr Purif. 2006;49:276-83 pubmed
|
Kobayashi M, Saitoh S, Tanimura N, Takahashi K, Kawasaki K, Nishijima M, et al. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J Immunol. 2006;176:6211-8 pubmed
|
Tada R, Nagi Miura N, Adachi Y, Ohno N. Candida albicans derived fungal PAMPS, CAWS, water soluble mannoprotein-beta-glucan complex shows similar immunotoxicological activity with bacterial endotoxin from Escherichia coli O9. Biol Pharm Bull. 2006;29:240-6 pubmed
|
Koraha J, Tsuneyoshi N, Kimoto M, Gauchat J, Nakatake H, Fukudome K. Comparison of lipopolysaccharide-binding functions of CD14 and MD-2. Clin Diagn Lab Immunol. 2005;12:1292-7 pubmed
|
Tsuneyoshi N, Fukudome K, Kohara J, Tomimasu R, Gauchat J, Nakatake H, et al. The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1. J Immunol. 2005;174:340-4 pubmed
|
5405 PB UDEN
Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.
As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.